The Role of Androgen Receptor and Antiandrogen Therapy in Breast Cancer: A Scoping Review

Breast cancer is a complex and highly heterogeneous disease, and its management is increasingly moving towards the principles of precision medicine. In this context, the androgen receptor (AR) has emerged as a promising therapeutic target, particularly within the challenging subgroup of triple-negat...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Antonio Ghidini, Roberta Bukovec, Luisa Roncari, Isabella Garassino, Fulvia Milena Cribiù, Fausto Petrelli
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2026-01-01
Cyfres:	Current Oncology
Pynciau:	androgen receptor triple-negative breast cancer luminal androgen receptor antiandrogen therapy enzalutamide bicalutamide
Mynediad Ar-lein:	https://www.mdpi.com/1718-7729/33/1/41
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!